PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, USA.\', \'Genetic Intelligence Laboratory, Weill Cornell Medicine-Qatar, Qatar Foundation, Doha, Qatar.\', \'Department of Genetic Medicine, Weill Cornell Medicine, New York, New York, USA.\', \'Deep Phenotyping Core, Research Branch, Sidra Medicine, Doha, Qatar.\', \'Department of Communicable Diseases Control, Ministry of Public Health, Doha, Qatar.\', \'Department of Immunology, Research Branch, Sidra Medicine, Doha, Qatar.\', \'Laboratoire CYTOPATH, Sousse, Tunisia.\', \'Ministry of Public Health, Doha, Qatar.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1172/jci.insight.145785145785
?:doi
?:hasPublicationType
?:journal
  • JCI insight
is ?:pmid of
?:pmid
?:pmid
  • 33529170
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all